EUVIMEDEUVIMED entdecken
Crossref

Treatment of bipolar disorder in pediatric population

Weronika Pawlak-Łukaszek, Martyna Bień, Lena Cichoń, Małgorzata Janas-Kozik

Pharmacotherapy in Psychiatry and Neurology · 2025 · 41 (2) · 83-96

DOI: 10.5114/fpn.2025.160138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2025. Verfasst von Weronika Pawlak-Łukaszek und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

2/2025 vol. 41 Review article Treatment of bipolar disorder in pediatric population Weronika D. Pawlak-Łukaszek 1 , Martyna P. Bień 1, 2 , Lena Cichoń 1, 2 , Małgorzata Janas-Kozik 1, 2 The John Paul II Child and Family Health Centre in Sosnowiec Ltd., Sosnowiec, Poland; Centrum Zdrowia Dziecka i Rodziny im. Jana Pawła II w Sosnowcu Sp. z o.o., Sosnowiec, Polska Department and Clinical Unit of Psychiatry and Psychotherapy of Developmental Age, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Katowice, Poland; Katedra i Oddział Kliniczny Psychiatrii i Psychoterapii Wieku Rozwojowego, Śląski Uniwersytet Medyczny w Katowicach, Katowice, Polska Farmakoterapia w Psychiatrii i Neurologii 2025 DOI: https://doi.org/10.5114/fpn.2025.160138 Online publish date: 2026/04/28 View full text Get citation Get citation ENW EndNote BIB JabRef, Mendeley RIS Papers, Reference Manager, RefWorks, Zotero AMA Pawlak-Łukaszek WD, Bień MP, Cichoń L, Janas-Kozik M. Treatment of bipolar disorder in pediatric population. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2025:83-96. doi:10.5114/fpn.2025.160138. APA Pawlak-Łukaszek, W. D., Bień, M. P., Cichoń, L., & Janas-Kozik, M. (2025). Treatment of bipolar disorder in pediatric population. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 83-96. https://doi.org/10.5114/fpn.2025.160138 Chicago Pawlak-Łukaszek, Weronika D, Martyna P Bień, Lena Cichoń, and Małgorzata Janas-Kozik. 2025. "Treatment of bipolar disorder in pediatric population". Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii: 83-96. doi:10.5114/fpn.2025.160138. Harvard Pawlak-Łukaszek, W., Bień, M., Cichoń, L., and Janas-Kozik, M. (2025). Treatment of bipolar disorder in pediatric population. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, pp.83-96. https://doi.org/10.5114/fpn.2025.160138 MLA Pawlak-Łukaszek, Weronika et al. "Treatment of bipolar disorder in pediatric population." Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 2025, pp. 83-96. doi:10.5114/fpn.2025.160138. Vancouver Pawlak-Łukaszek W, Bień M, Cichoń L, Janas-Kozik M. Treatment of bipolar disorder in pediatric population. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2025:83-96. doi:10.5114/fpn.2025.160138. ObjectivesThis article aims to present current information on the treatment of bipolar disorder (BD) in children and adolescents, including pharmacotherapy and psychosocial interventions.Literature reviewCurrent guidelines and recent scientific studies on the treatment of BD in children and adolescents were reviewed, with particular attention to the use of antipsychotic medications such as cariprazine, ziprasidone, asenapine, paliperidone and lurasidone.ConclusionsTreatment of BD in the paediatric population must take into account differences in the clinical presentation of the disorder in this age group, as well as differences in response to therapeutic strategies compared with adults. Many second-generation antipsychotics have been approved by the U.S. Food and Drug Administration for the treatment of manic or mixed episodes in the paediatric population. They are often considered first-line treatments because of their effectiveness; however, metabolic adverse effects may limit their use. Antidepressant monotherapy is not recommended for depressive episodes. Psychosocial interventions also play an important role in the treatment of BD; however, no specific psychotherapeutic approach has yet been firmly established for children and adolescents with this disorder. Further research is therefore required on both pharmacotherapy and psychosocial interventions in order to identify safer, more effective and better-tolerated treatment options for manic and depressive symptoms, while also taking into account the frequent comorbidities observed in this age group. Keywords bipolar disorder, pharmacological treatment, children, adolescents, pediatric population

Zitieren

APA

Pawlak-Łukaszek, W., Bień, M., Cichoń, L., & Janas-Kozik, M. (2025). Treatment of bipolar disorder in pediatric population. Pharmacotherapy in Psychiatry and Neurology, 41(2), 83-96. https://doi.org/10.5114/fpn.2025.160138

Vancouver

Pawlak-Łukaszek W, Bień M, Cichoń L, Janas-Kozik M. Treatment of bipolar disorder in pediatric population. Pharmacotherapy in Psychiatry and Neurology. 2025;41(2):83-96. doi:10.5114/fpn.2025.160138

BibTeX
@article{Pawlakukaszek2025,
  author = {Pawlak-Łukaszek, Weronika and Bień, Martyna and Cichoń, Lena and Janas-Kozik, Małgorzata},
  title = {Treatment of bipolar disorder in pediatric population},
  journal = {Pharmacotherapy in Psychiatry and Neurology},
  year = {2025},
  volume = {41},
  number = {2},
  pages = {83--96},
  doi = {10.5114/fpn.2025.160138}
}
Kostenlos starten →